Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

01/08/2019 04:00

Aug 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               73.98               71.24           290.00    
                   (+3.8 pct)          (+17.0 pct)      (+0.5 pct)  
  Operating           19.98               17.98            67.00    
                   (+11.1 pct)         (+26.0 pct)      (+8.0 pct)  
  Pretax              21.20               19.43            70.00    
                   (+9.1 pct)          (+23.0 pct)      (+7.5 pct)  
  Net                 16.33               15.24            53.00    
                   (+7.2 pct)          (+29.4 pct)      (+2.8 pct)  
  EPS Basic         31.84 yen           29.64 yen       103.09 yen  
  EPS Diluted       31.84 yen           29.63 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div                               22.50 yen        22.50 yen  
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T